Home > Healthcare > Pharmaceuticals > Finished Drug Form > Heparin Market
Heparin Market Share
- Report ID: GMI4837
- Published Date: Feb 2022
- Report Format: PDF
Heparin Market Share
- Shenzhen Hepalink
- Nanjing King-Friend Biochemical Pharmaceutical
- Fresenius Kabi
- Changzhou Qianhong Biopharma
- Yantai Dongcheng Biochemicals Co., Ltd.
Frequently Asked Questions (FAQ) :
In 2022, the heparin industry size was valued at more than USD 4.8 billion in 2022 and will grow at over 2.5% CAGR from 2023 to 2032, attributed to the growing occurrence of chronic disorders globally.
The low molecular weight heparin industry was worth over USD 4.2 billion in 2022, owing to the rising prevalence of deep vein thrombosis.
Europe heparin market held more than 58.5% market share in 2022, on account of the surging prevalence of venous thromboembolism, ischemic heart disease, and other cardiovascular diseases that lead to blood clot formation in the region.
Major heparin industry players include Amphastar, Leo Pharma, Rovi, Sanofi, Changzhou Qianhong Biopharma, Pfizer, Shenzhen Hepalink, and Nanjing King-Friend Biochemical Pharmaceutical, among others.
Heparin Market Scope
×
Get a free sample of
Heparin Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below